Australia markets open in 21 minutes

Centogene N.V. (CNTG)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.9477+0.0194 (+2.09%)
At close: 03:57PM EST
0.9300 -0.02 (-1.87%)
After hours: 05:10PM EST

Centogene N.V.

Am Strande 7
Rostock 18055
Germany
49 381 80113 500
https://www.centogene.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees444

Key executives

NameTitlePayExercisedYear born
Ms. Kim StrattonCEO & Member of Management Board932.89kN/A1962
Mr. Jose Miguel Coego RiosCFO, Legal & IT and Member of Management Board323.97kN/AN/A
Dr. Peter Bauer M.D.Chief Medical & Genomic Officer and Member of Management Board186.36kN/A1970
Dr. Andrin Oswald M.D., Ph.D.Advisor943.73kN/A1972
Mr. Ian RentschChief Commercial Officer & GM of PharmaN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.

Corporate governance

Centogene N.V.’s ISS governance QualityScore as of 1 February 2024 is 7. The pillar scores are Audit: 4; Board: 6; Shareholder rights: 5; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.